We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

  • Facebook
  • Twitter
  • Linked In
  • Google+
back top

Director Hurtig Mark

Hurtig Mark

University of Guelph
Clinical Studies
Guelph, Canada

Professor Mark Hurtig is the director of the Canadian Arthritis Network Strategic Research Resource Laboratory at the University of Guelph in Canada which focuses on animal models and translational studies to facilitate regulatory approval of new therapies for clinical use. His work includes industrial and academic collaborations on osteoarthritis mechanisms, identifying disease modifying therapies, and cartilage repair strategies. He has been the primary investigator for two human knee injury research studies centred in Toronto that study factors driving knee OA progression after injury (www.proknee.ca) and patient-specific optimization of arthroscopic microfracture—a technique used for cartilage repair. He work includes collaborations in tissue engineering, computer-assisted surgery, intra-articular medication, biologics and imaging.